PATENT CLAIM ANALYSIS

Application Number: 16059909
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "265100"]

Abstract:
The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.

Claim (Index 1):
A compound of formula I-C or formula I-D: or a pharmaceutically acceptable salt thereof, wherein\n R 4  is \u2014NR 6 R 6\u2032 , \u2014NH\u2014O\u2014R 6  or \u2014NH\u2014NR 6 R 6\u2032 ; \n R 5  is H or F; \n R 6  and R 6\u2032  are each independently H or \u2014C 1 -C 6 alkyl; \n heteroaryl is quinolinyl, substituted quinolinyl, indolyl, substituted indolyl, indazolyl, substituted indazolyl, imidazo[1,2-a]pyridinyl, or substituted imidazo[1,2-a]pyridinyl; and \n aryl is phenyl or substituted phenyl.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.29167
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15045679', '15612030', '14982127', '12310597', '12903554']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8110785997921404
- 35 USC 102 Novelty (BERT): 0.5478415647238754
- Combined Prediction Score: 0.7847548962853139
- Mean Citation Score: 329.233022
- Max Citation Score: 414.93246
- Similarity Product: 296.26995715957764

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test